IGM Biosciences Inc (IGMS) — Financial Flexibility Index
IGM Biosciences Inc (IGMS) has a Financial Flexibility Index of -8.38x as of June 2025. Free cash flow of $-50.79 Million (operating CF $-50.79 Million minus capex $1.00K) represents -8% of total liabilities ($6.06 Million). Check IGMS total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
IGM Biosciences Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for IGM Biosciences Inc across 8 annual periods. For the full cash flow conversion analysis, see IGMS cash flow metrics.
Annual Financial Flexibility Index for IGM Biosciences Inc (2017–2024)
Year-by-year free cash flow to debt coverage for IGM Biosciences Inc. Explore IGM Biosciences Inc (IGMS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.68x | $-147.14 Million | $-153.00 Million | $217.54 Million | ▲ +17.2% |
| 2023 | -0.82x | $-179.85 Million | $-192.23 Million | $220.18 Million | ▼ -4345.3% |
| 2022 | 0.02x | $4.35 Million | $-5.85 Million | $226.24 Million | ▲ +100.9% |
| 2021 | -2.09x | $-111.09 Million | $-124.34 Million | $53.22 Million | ▼ -12.4% |
| 2020 | -1.86x | $-49.80 Million | $-67.30 Million | $26.82 Million | ▲ +8.3% |
| 2019 | -2.03x | $-42.78 Million | $-45.12 Million | $21.12 Million | ▼ -634.3% |
| 2018 | -0.28x | $-19.26 Million | $-20.04 Million | $69.81 Million | ▼ -15.9% |
| 2017 | -0.24x | $-9.97 Million | $-10.36 Million | $41.89 Million | — |